搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
7 小时
on MSN
Weight loss drugs like Ozempic, Wegovy are all the rage. Are they safe for kids?
Doctors say early obesity intervention can help prevent later health problems. But prescribing GLP-1s, such as Ozempic and ...
10 小时
Weight-loss drugs deliver life-changing health benefits - and big profits
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
2 小时
on MSN
Gastric balloon being tested as alternative to weight-loss surgery, GLP-1 meds
Researchers have developed and are testing a small, implanted gastric balloon that people can inflate or deflate to feel full ...
TAG24 NEWS on MSN
1 分钟
Weight loss drugs are all the rage. Are they safe for kids?
Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as an alternative to the traditional - and often ineffective - advice to "eat ...
9 小时
We revealed weight-loss drug inequality in New York. Here's why your stories matter
Ozempic, Wegovy, and other weight-loss drugs could make millions healthier, but access and affordability barriers abound.
7 小时
Why do people on Ozempic and other obesity drugs lose interest in alcohol
Weight loss medications like Ozempic, Wegovy, and Mounjaro are not only effective in curbing appetite but also in reducing ...
HealthDay on MSN
12 小时
About One-Third Eligible for Weight Loss Drugs Meet Trial Exclusion Criteria
About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 ...
14 小时
Exclusive: Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular ...
24/7 Wall St
1 小时
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
6 小时
on MSN
After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?
There's a growing number of companies entering the weight loss space, focusing on GLP-1 drugs which can be game changers for ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈